Revolution Medicines, Inc. Quarterly Operating Margin in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Revolution Medicines, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
  • Revolution Medicines, Inc. Operating Margin for the quarter ending September 30, 2024 was -88K %, a 6144% decline year-over-year.
  • Revolution Medicines, Inc. annual Operating Margin for 2023 was -4.21K %, a 476% decline from 2022.
  • Revolution Medicines, Inc. annual Operating Margin for 2022 was -730 %, a 14.1% decline from 2021.
  • Revolution Medicines, Inc. annual Operating Margin for 2021 was -640 %, a 148% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -88K -86.6K -6144% Jul 1, 2024 Sep 30, 2024
Q2 2024 -81K -79.9K -7319% Apr 1, 2024 Jun 30, 2024
Q1 2024 -12.1K -11.3K -1430% Jan 1, 2024 Mar 31, 2024
Q4 2023 -4.21K -3.48K -476% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.41K -564 -66.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.09K -262 -31.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -791 -14.1 -1.82% Jan 1, 2023 Mar 31, 2023
Q4 2022 -730 -90.3 -14.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -845 -256 -43.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -830 -473 -133% Apr 1, 2022 Jun 30, 2022
Q1 2022 -777 -472 -154% Jan 1, 2022 Mar 31, 2022
Q4 2021 -640 -382 -148% Oct 1, 2021 Dec 31, 2021
Q3 2021 -590 -382 -184% Jul 1, 2021 Sep 30, 2021
Q2 2021 -357 -179 -100% Apr 1, 2021 Jun 30, 2021
Q1 2021 -306 -172 -128% Jan 1, 2021 Mar 31, 2021
Q4 2020 -258 -149 -138% Oct 1, 2020 Dec 31, 2020
Q3 2020 -208 Jul 1, 2020 Sep 30, 2020
Q2 2020 -178 Apr 1, 2020 Jun 30, 2020
Q1 2020 -134 Jan 1, 2020 Mar 31, 2020
Q4 2019 -108 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.